Skip to main content

Security report for hizentrapatientprogram.com

CSL Behring (implied from domain and content references) · Healthcare · United States

Medium risk. 1 critical or high finding in SSL/TLS.

Security score

67/100

Risk levelMedium

0–100, higher is better. How it is calculated

The Hizentra Patient Program website serves as an online registration portal for educational programs targeting patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Primary Immune Deficiency (PI). The site is likely operated or sponsored by CSL Behring, a reputable pharmaceutical company, as indicated by domain references and content. The platform provides event registration for live and webinar programs featuring healthcare professionals and patient advocates. Technically, the site is built on ASP.NET WebForms with Telerik UI components, supplemented by jQuery and Google Tag Manager for analytics. The presence of a OneTrust cookie consent banner demonstrates attention to privacy compliance, although no explicit privacy policy or terms of service were found in the provided content. Security posture is moderate with HTTPS enabled and domain registration protections in place, but lacks visible security headers and explicit incident response or vulnerability disclosure information. Overall, the website is professional, trustworthy, and serves a niche healthcare audience effectively.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

1 finding rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      Unable to retrieve SSL certificate

      Could not establish secure connection to retrieve certificate information

      What to do: Check if the server is accessible and SSL/TLS is properly configured

Need hands-on remediation? Email guard@offseq.com

Keep watching hizentrapatientprogram.com

This scan found 15 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
70
Email security
70
DNS health
75
Network security
100
GDPR outside view
88
Average
67

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website positions itself as a specialized patient education and support platform within the healthcare sector, focusing on rare immune disorders. Its business model revolves around providing free educational programs to patients and caregivers, likely funded by the pharmaceutical company CSL Behring. The site targets a specific patient demographic, enhancing patient engagement and brand trust. The use of established domain registration and cookie consent tools indicates a mature approach to compliance and digital presence. However, the absence of direct contact information and detailed policies may limit user trust and engagement. The platform's partnership ecosystem appears limited to internal or related pharmaceutical entities, with no external business partners explicitly identified.

Security posture

The website demonstrates a baseline security posture with HTTPS enforced and domain status locks preventing unauthorized transfers or deletions. However, the lack of visible security headers such as Content-Security-Policy, X-Frame-Options, and HSTS reduces its defense-in-depth capabilities. No incident response contacts or vulnerability disclosure mechanisms are present, which could hinder timely security issue reporting and resolution. The use of third-party scripts like Google Tag Manager and OneTrust requires ongoing monitoring to mitigate supply chain risks. Overall, while no critical vulnerabilities were detected, there is room for improvement in implementing comprehensive security best practices and transparency.

Recommendations

  1. Implement and publish a comprehensive privacy policy and terms of service to enhance user trust and compliance.
  2. Add security headers including Content-Security-Policy, X-Frame-Options, X-XSS-Protection, and Strict-Transport-Security to strengthen security posture.
  3. Provide clear contact information including support emails and phone numbers to improve user engagement and trust.
  4. Establish and publicize a vulnerability disclosure policy or security.txt file to facilitate responsible security reporting.
  5. Regularly audit and update third-party scripts and libraries to mitigate potential vulnerabilities and supply chain risks.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
CSL Behring (implied from domain and content references)
Description
The website provides online registration for Hizentra Patient Speaker Programs, which are free educational programs for patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Primary Immune Deficiency (PI). The programs include presentations by trained nurses and patient advocates.
Key services
Patient educational programs, Event registration (live events and webinars)
Content quality
good
Branding
consistent

Technology

Stack
ASP.NET WebForms, Telerik UI components, jQuery, Google Tag Manager, OneTrust Cookie Consent
Frameworks
ASP.NET, Telerik
Platforms
Windows Server (implied by ASP.NET)
Performance
moderate
Mobile
good
Accessibility
basic
SEO
basic

Security

Observed score
65/100
Good practices seen
  • HTTPS enforced
  • ClientDeleteProhibited, clientTransferProhibited, clientUpdateProhibited domain statuses

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
basic

Advertising

Marketing tools
OneTrust Cookie Consent
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a patient program registration portal for Hizentra, a pharmaceutical product.
  2. Uses ASP.NET WebForms with Telerik UI components, indicating a traditional enterprise web application.
  3. Includes OneTrust cookie consent banner, indicating GDPR and privacy compliance efforts.
  4. No explicit privacy policy or terms of service found in the provided content.
  5. No direct contact emails or phone numbers found on the main page content.
  6. Google Tag Manager is used for analytics and tracking; Google Analytics script is present but disabled.
  7. No security.txt or vulnerability disclosure page detected.
  8. No social media links detected in the provided content.
  9. No explicit security headers detected in the provided data; potential area for improvement.
Technical notes

Notes

The website utilizes a traditional ASP.NET WebForms architecture with Telerik UI components, indicating an enterprise-grade but somewhat dated technology stack. The inclusion of jQuery and Google Tag Manager reflects standard web analytics and interactivity practices. The site appears moderately optimized for mobile devices and accessibility, though no advanced CMS or modern frontend frameworks were detected. Performance is moderate, likely influenced by the legacy framework and multiple external scripts. There is an opportunity to modernize the technology stack to improve performance, maintainability, and security. Hosting details are not explicit but domain registration via MarkMonitor suggests professional management.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with hizentrapatientprogram.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review hizentrapatientprogram.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.